Cancer is a large group of diseases, most of them serious and widespread throughout the world. In 2022, it is estimated that there will be 20 million new cases of cancer and 9.7 million deaths. Around 1 in 5 people develop cancer during their lifetime, around 1 in 9 men and 1 in 12 women die from it.
Immunotherapy represents a cutting-edge and increasingly vital approach in the fight against cancer. Unlike traditional treatments such as chemotherapy and radiotherapy, which directly target cancer cells, immunotherapy engages the body's immune system, allowing it to recognize and fight cancer cells.
The evolution of immunotherapy has marked a paradigm shift in oncology, offering new hopes and new treatment avenues. The objective of the “Cancer Immunotherapies” course is to introduce the rapidly evolving field of cancer immunotherapy, offering new hopes and new challenges. Students in this dynamic discipline will be encouraged to delve deeper into the mechanisms, applications and future prospects of immunotherapies in the treatment of cancer.
